Cargando…
Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression
Hepatic steatosis is the main characteristic of some liver metabolism diseases. However, unclear molecular mechanism of hepatic steatosis impedes the therapy of this hepatic steatosis. Glutathione-S-transferase mu 2 (GSTM2), as a member of phase II drug metabolizing enzymes (DMEs), regulates cellula...
Autores principales: | Jin, Yi, Tan, Yanjie, Zhao, Pengxiang, Guo, Yu, Chen, Shilin, Wu, Jian, Ren, Zhuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986781/ https://www.ncbi.nlm.nih.gov/pubmed/35388144 http://dx.doi.org/10.1038/s42003-022-03251-w |
Ejemplares similares
-
Evaluation of Genetic Polymorphisms in Glutathione S-Transferase Theta1, Glutathione S-Transferase Mu1, and Glutathione S-Transferase Mu3 in Oral Leukoplakia and Oral Squamous Cell Carcinoma with Deleterious Habits using Polymerase Chain Reaction
por: Rao, Ayyagari Kameswara, et al.
Publicado: (2017) -
Autophagy activation contributes to glutathione transferase Mu 1-mediated chemoresistance in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2018) -
Expressions of glutathione S-transferase alpha, mu, and pi in brains of medically intractable epileptic patients
por: Shang, Wei, et al.
Publicado: (2008) -
Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma
por: Wang, Shou-Chieh, et al.
Publicado: (2016) -
Identification and verification of the prognostic value of the glutathione S-transferase Mu genes in gastric cancer
por: Chen, Yeyang, et al.
Publicado: (2020)